Unlocking the Power of the SH800 Cell Sorter: Insights from Gene Editing to Immunology
The SH800 Cell Sorter from Sony Biotechnology is a versatile solution designed to deliver exceptional sorting performance across a wide array of applications. Tailored to meet diverse user needs, it incorporates built-in automation and intuitive workflows that make it accessible even to researchers with limited sorting experience. At the heart of the system’s innovative design is the interchangeable microfluidics chip, which facilitates high-throughput sorting while ensuring gentle cell handling to minimize stress and preserve cell viability and functionality.
Join our upcoming webinar to explore how researchers from various disciplines utilize the SH800 Cell Sorter to produce high-quality data. The session will feature four case studies highlighting its applications in gene editing, stem cell biology, immunology, and genomics. Learn how the SH800 Cell Sorter streamlines the isolation of target cells, ensuring effortless and reliable sorting of cells for further use in downstream assays.
Key Learning Objectives:
- Learn how to streamline workflows with automated setup on the SH800 Cell Sorter.
- Discover how the SH800 Cell Sorter's innovative design and key features support the sorting of various cell types.
- Explore the versatile applications of the SH800, including CRISPR gene editing, immune and stem cell isolation, and single-cell sorting for genomics assays.
Who should attend
This webinar will benefit researchers who are new to sorting or who work in the areas of gene editing, immunology, or stem cell biology and would like to use cell sorting technology in their research.
Speaker
Andy Draghi, PhD
Field Applications Scientist
Sony Biotechnology
Andy Draghi is passionate about helping researchers improve their flow cytometry approaches by providing top-level consultative support and guidance, from sample to solution. Prior to joining Sony, Andy worked in the high-parameter segment of a life science research provider and as a research scientist in early clinical development at a pharmaceutical company. He completed post-doctoral training at the NEAG Cancer Center (Department of Immunology), University of Connecticut Health Center and at the Connecticut Children’s Medical Center. Andy received his PhD from the University of Connecticut, where he studied molecular characterization of novel Chlamydia-like bacteria.